|
業務類別
|
Biotechnology |
|
業務概覽
|
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer. |
| 公司地址
| 44 Milton Avenue, Alpharetta, GA, USA, 30009 |
| 電話號碼
| +1 866 620-8655 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.virios.com |
| 員工數量
| 8 |
| Dr. Roger Michael Gendreau, M.D.,PhD |
Chief Medical Officer |
美元 366.08K |
27/04/2026 |
| Mr. Gregory Duncan |
Chief Executive Officer and Chairman of the Board |
美元 577.00K |
27/04/2026 |
| Mr. Ralph Grosswald |
Senior Vice President, Operations |
-- |
27/04/2026 |
| Ms. Angela Walsh |
Chief Financial Officer, Corporate Secretary, Principal Accounting Officer and Treasurer |
美元 300.91K |
27/04/2026 |
|
|
| Mr. John C. Thomas,Jr |
Independent Director |
27/04/2026 |
| Dr. Abel De La Rosa,PhD |
Independent Director |
27/04/2026 |
| Dr. Richard J. Whitley,M.D. |
Independent Director |
27/04/2026 |
| Mr. Gregory Duncan |
Chief Executive Officer and Chairman of the Board |
27/04/2026 |
| Mr. Ying Choi Alan Abel Yu |
Director |
27/04/2026 |
| Mr. David Keefer |
Independent Director |
27/04/2026 |
| Dr. Melvin Toh, PhD |
Director |
27/04/2026 |
|
|
|
|
